Related Experiment Video
Updated: Mar 3, 2026

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library
Published on: April 6, 2012
MicroRNA‑336 directly targets Sox‑2 in osteosarcoma to inhibit tumorigenesis
Yong Cao1, Tianding Wu1, Dongzhe Li1
1Department of Spine Surgery, Xiangya Hospital, Central South University, Changsha, Hunan 410008, P.R. China.
Abstract:
Previous evidence has suggested that microRNAs (miRNAs or miRs), which belong to a class of non‑coding RNAs, shape cellular processes by regulating gene expression. Abnormal expression of miRNAs has been associated with tumorigenesis in multiple cancers. However, the function of miR‑336 in osteosarcoma (OS) remains unknown. The experimental procedures used in the present study included flow cytometry, reverse transcription‑quantitative polymerase chain reaction, luciferase reporter assay, invasion assay, western blot analysis and in vivo implantation. The results of the present study demonstrated that miR‑336 may serve as a tumor suppressor in OS. Downregulation of miR‑336 was observed in human OS specimens as well as OS cell lines. In addition, a significant negative correlation between sex determining region Y‑box 2 (Sox‑2) expression and miR‑336 was demonstrated. miR‑336 was confirmed to target the 3'‑untranslated region of Sox‑2 to inhibit proliferation, migration and invasion of OS cells. Consistently, restoration of Sox‑2 expression counteracted the effect of miR‑336, and recovered the tumorigenic potential of OS cells. The present study established a novel association between miR‑336 and Sox‑2 in OS. This relationship between miR‑336 and Sox‑2 may lead to improved knowledge concerning OS progression and sheds light on potential novel therapeutic interventions for OS treatment.
Insights
MicroRNA-336 (miR-336) acts as a tumor suppressor in osteosarcoma (OS). It inhibits OS cell proliferation, migration, and invasion by targeting SOX-2, offering potential therapeutic strategies.
Area of Science:
- Molecular Biology
- Oncology
- Biochemistry
Background:
- MicroRNAs (miRNAs) regulate gene expression and are implicated in cancer development.
- The role of miR-336 in osteosarcoma (OS) has not been previously elucidated.
- Understanding miRNA functions is crucial for cancer research and therapeutic development.
Purpose of the Study:
- To investigate the function of miR-336 in osteosarcoma.
- To determine the relationship between miR-336 and SOX-2 in OS.
- To explore the potential of miR-336 as a therapeutic target for OS.
Main Methods:
- Flow cytometry
- Reverse transcription-quantitative polymerase chain reaction (RT-qPCR)
- Luciferase reporter assay
- Invasion assay
- Western blot analysis
- In vivo implantation models
Main Results:
- miR-336 was downregulated in human OS specimens and cell lines.
- A negative correlation was observed between miR-336 and sex determining region Y-box 2 (SOX-2) expression.
- miR-336 directly targets the 3'-untranslated region of SOX-2, inhibiting OS cell proliferation, migration, and invasion.
- Restoration of SOX-2 expression reversed the tumor-suppressive effects of miR-336.
Conclusions:
- miR-336 functions as a tumor suppressor in osteosarcoma.
- The miR-336/SOX-2 axis plays a significant role in OS progression.
- This finding provides novel insights into OS pathogenesis and suggests potential therapeutic strategies targeting the miR-336-SOX-2 pathway.
Related Concept Videos
MicroRNAs
MicroRNAs
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

